We are live on ! Find out more
CL

CIM LLC Portfolio holdings

AUM $692M
1-Year Est. Return 22.9%
This Fund
S&P 500
This Quarter Est. Return
+8.23%
1 Year Est. Return
+22.9%
3 Year Est. Return
+92.08%
5 Year Est. Return
+131%
10 Year Est. Return
+651.69%
AUM
$504M
AUM Growth
+$29.7M
Cap. Flow
-$5.24M
Cap. Flow %
-1.04%
Top 10 Hldgs %
33.18%
Holding
162
New
13
Increased
40
Reduced
90
Closed
13

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.79%
2 Technology 14.03%
3 Financials 13.96%
4 Healthcare 13.74%
5 Industrials 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLFD icon
151
Clearfield
CLFD
$459M
-2,794
Closed -$332K
DVY icon
152
iShares Select Dividend ETF
DVY
$23.5B
-3,071
Closed -$364K
EXEL icon
153
Exelixis
EXEL
$14.3B
-46,590
Closed -$783K
GLOB icon
154
Globant
GLOB
$1.66B
-5,184
Closed -$978K
IIPR icon
155
Innovative Industrial Properties
IIPR
$1.7B
-2,485
Closed -$277K
IVE icon
156
iShares S&P 500 Value ETF
IVE
$49.7B
-2,486
Closed -$357K
NNDM
157
Nano Dimension
NNDM
$328M
-11,500
Closed -$28K
NVR icon
158
NVR
NVR
$17B
-245
Closed -$1.04M
PFE icon
159
Pfizer
PFE
$147B
-32,281
Closed -$1.55M
RGEN icon
160
Repligen
RGEN
$8.95B
-4,261
Closed -$791K
TSLA icon
161
Tesla
TSLA
$1.27T
-3,164
Closed -$721K
URG
162
Ur-Energy
URG
$517M
-17,000
Closed -$22K

Similar funds

CIM LLC's Q4 2022 Portfolio in Review

As of Q4 2022, CIM LLC held 162 positions worth $504M, up 6.3% from $474M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

CIM LLC's Q4 2022 filing shows 13 new, 40 increased, 90 reduced and 13 closed positions. Its largest new stake was Lennar Class A: 32,822 shares worth $3.2M. The largest sale was Novo Nordisk, an estimated $4.94M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • CIM LLC's largest Q4 2022 buy was Lennar Class A: 32,822 shares worth $3.2M.
  • CIM LLC added most to Intuit in Q4 2022, an estimated $3.23M increase.
  • CIM LLC's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $4.94M.
  • CIM LLC fully exited Pfizer in Q4 2022, selling an estimated $1.55M.
  • CIM LLC's ten largest holdings make up 33% of its $504M portfolio in Q4 2022.
  • CIM LLC opened 13 new positions and closed 13 in Q4 2022.
  • CIM LLC's portfolio value rose 6.3% quarter-over-quarter to $504M.

Based on CIM LLC's 13F filing for Q4 2022, filed 10 Feb 2023.